6 Stocks Poised For Potential Acquisition In The Next 12 Months, According To Goldman Sachs, Including A 200% YTD Gainer - (AACT), Walt Disney (NYSE:DIS)

Core Insights - Goldman Sachs has identified six stocks with a high probability of being acquisition targets in the next year, with chances ranging from 30% to 50% [3][8] - The total dollar value of M&A deals has increased by 29% year-over-year, with deal volumes projected to rise by 8% in 2025 and an additional 15% increase expected in 2026 [2][4] Stock Highlights - Insmed (NASDAQ:INSM): Health care sector, 102.50% year-to-date growth, 92nd percentile for Momentum [3] - Madrigal Pharmaceuticals (NASDAQ:MDGL): Health care sector, 41.21% year-to-date growth, momentum rating of 89.62% [3] - Krystal Biotech (NASDAQ:KRYS): Health care sector, 12.94% year-to-date growth, value score of 27.40% [3] - Mineralys Therapeutics (NASDAQ:MNTA): Health care sector, 221.22% year-to-date growth, 97th percentile for momentum [3] - TripAdvisor (NASDAQ:TRIP): Travel sector, 13.74% year-to-date growth, momentum rating of 68.47% [3] - Vera Therapeutics (NASDAQ:VERA): Health care sector, 31.52% year-to-date decline, stronger short and medium-term price trend [3] Market Performance - The identified stocks have outperformed the S&P 1500 by seven percentage points since the start of September, coinciding with increased M&A activity [4] - The M&A landscape has been active in 2025, highlighted by Electronic Arts' $55 billion all-cash acquisition, which has positively impacted the stock prices of potential M&A targets [5]